Literature DB >> 26724262

Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study.

Sangita V Patel1, Kapil B Nimavat2, Patel B Alpesh3, Lipy K Shukla4, Kalpita S Shringarpure5, Kedar G Mehta6, Chakshu C Joshi7.   

Abstract

Multidrug-resistant TB has become a significant public health problem in a number of countries and an obstacle to effective TB control. Therefore, the present study sought to determine the treatment outcome in patients with MDR TB in seven districts and to examine the factors affecting the treatment outcome. A prospective cohort study was carried out by enrolling all the registered patients in DOTs Plus center of Vadodara district from February 2010 to December 2010. A total of 142 patients were interviewed using a pre-tested semi-structured questionnaire at the DOTS centers of seven districts of Gujarat or at their homes in cases of defaulters/death. After 24 months, of those 145 patients, 48 (33.10%) were declared cured, 8 (5.50%) had completed their treatment, 43 (29.70%) patients died during the treatment, and 32 (21.10%) patients defaulted during treatment. Factors associated with a significant difference in the outcomes were income, marital status, and education. Only education significantly affected treatment outcome upon applying logistic regression. Therefore, proper counseling on drug adherence should be applied at the programmatic level.
Copyright © 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Defaulter; Multidrug-resistant tuberculosis; Treatment outcome; Treatment success rate

Mesh:

Substances:

Year:  2015        PMID: 26724262     DOI: 10.1016/j.jiph.2015.11.011

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  10 in total

1.  Socioepidemiological status and clinical outcome of MDR TB patients in a tertiary medical college in Southern Odisha.

Authors:  Manoranjan Dash; Bibhu Prasad Behera
Journal:  J Family Med Prim Care       Date:  2022-03-18

2.  Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.

Authors:  Poonam Ramesh Naik; Patrick K Moonan; Abhay Subhashrao Nirgude; Hemant Deepak Shewade; Srinath Satyanarayana; Pracheth Raghuveer; Malik Parmar; Chinnappareddy Ravichandra; Anil Singarajipura
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

3.  Drug-resistant tuberculosis - A ticking time bomb!

Authors:  Srikanth Krishnamurthy
Journal:  Perspect Clin Res       Date:  2018 Oct-Dec

4.  Treatment outcome of multidrug-resistant tuberculosis with modified DOTS-plus strategy: A 2 years' experience.

Authors:  Abhijeet Singh; Rajendra Prasad; Ram Awadh Singh Kushwaha; Rahul Srivastava; Belur Hosmane Giridhar; Viswesvaran Balasubramanian; Amita Jain
Journal:  Lung India       Date:  2019 Sep-Oct

5.  Unfavorable Treatment Outcome and Its Predictors Among Patients with Multidrug-Resistance Tuberculosis in Southern Ethiopia in 2014 to 2019: A Multi-Center Retrospective Follow-Up Study.

Authors:  Lemlem Bogale; Tewodros Tsegaye; Mohamed Abdulkadir; Temesgen Yihunie Akalu
Journal:  Infect Drug Resist       Date:  2021-04-08       Impact factor: 4.003

6.  "Side effects--part of the package": a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India.

Authors:  Arjunkumar Jakasania; Kalpita Shringarpure; Dixit Kapadia; Radhika Sharma; Kedar Mehta; Arpit Prajapati; Soundappan Kathirvel
Journal:  BMC Infect Dis       Date:  2020-12-02       Impact factor: 3.090

7.  Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan.

Authors:  Farman Ullah Khan; Asim Ur Rehman; Faiz Ullah Khan; Khezar Hayat; Amjad Khan; Nafees Ahmad; Jie Chang; Usman Rashid Malik; Yu Fang
Journal:  Int J Environ Res Public Health       Date:  2022-01-29       Impact factor: 3.390

8.  Treatment Outcome of MDR/RR TB in a Resource-Constrained Setup: A Four-Year Retrospective Analysis.

Authors:  Abdurahman Abibeker Omer; Meiraf Daniel Meshesha; Abraham Teka Ajema; Samuel D Yoo
Journal:  Infect Drug Resist       Date:  2022-08-22       Impact factor: 4.177

9.  Treatment Outcomes Associated with Multidrug-resistant Tuberculosis.

Authors:  Nitin Gupta; Pankaj Jorwal
Journal:  J Glob Infect Dis       Date:  2018 Jul-Sep

10.  Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.

Authors:  Demelash Woldeyohannes; Tesfaye Assefa; Rameto Aman; Yohannes Tekalegn; Zeleke Hailemariam
Journal:  PLoS One       Date:  2019-10-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.